Surgical & Cosmetic Dermatology (Nov 2023)

New indication for calcium hydroxyapatite: safe rejuvenation of the dorsum of the foot based on anatomy

  • Bhertha Miyuki Tamura

DOI
https://doi.org/10.5935/scd1984-8773.2023150003
Journal volume & issue
Vol. 15

Abstract

Read online

INTRODUCTION: For religious reasons, a portion of the population does not expose their body, showing only the feet. OBJECTIVE: This study aimed to meet the demand for treatments to rejuvenate the dorsum of the foot, observe the safety of using calcium hydroxyapatite and its results, and discuss the region anatomy. METHODS: Sixty women with an average age of 63 years and skin phototypes from I to VI had the dorsum of their foot's age classified by types from I to VII, and were injected with 0.75 ml to 3 ml of calcium hydroxyapatite per patient in this region, in a single session. A dermatologist who did not participate in the treatment and the patients conducted the evaluation through photos. RESULTS: The results were considered good to very good depending on the aging stage of the dorsum of the feet. Complications were limited to local edema and erythema. Follow-up lasted from six months to one year. CONCLUSION: The injection of calcium hydroxyapatite into the dorsum of the feet, based on knowledge of the anatomy of this region and correct volume, could be considered a body area treatment.

Keywords